New drug aims to ease agony after knee surgery

NCT ID NCT06799845

Summary

This study tested whether a new drug called ATX101 could reduce pain after knee replacement surgery. Researchers compared ATX101 against a placebo (saltwater injection) and a standard pain medication (bupivacaine) in 226 adults having knee replacement. The main goals were to see if ATX101 was better at controlling pain and if it helped patients use fewer opioid painkillers after surgery.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TOTAL KNEE ARTHROPLASTY (POSTOPERATIVE PAIN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Atlanta Centre for Medical Research

    Atlanta, Georgia, 30331, United States

  • Chesapeake Research Group, LLC

    Pasadena, Maryland, 21122, United States

  • Endeavor Clinical Trials, LLC

    San Antonio, Texas, 78240, United States

  • First Surgical Hospital

    Bellaire, Texas, 77401, United States

  • JBR Clinical Research, LLC

    Salt Lake City, Utah, 84107, United States

  • Legent Orthopedic Hospital

    Carrollton, Texas, 75006, United States

  • Memorial Hermann Village

    Houston, Texas, 77043, United States

  • NextStage Clinical Research

    Wichita, Kansas, 67214, United States

  • NextStage Clinical Research

    San Antonio, Texas, 78258, United States

  • Phoenix Clinical Research

    Tamarac, Florida, 33321, United States

  • Woodland International Research Group, LLC

    Little Rock, Arkansas, 72211, United States

Conditions

Explore the condition pages connected to this study.